//
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block